The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Parkin Mediates Neuroprotection through Activation of IκB Kinase/Nuclear Factor-κB Signaling
Abstract
Mutations in the parkin gene are a major cause of autosomal recessive Parkinson's disease. Here we show that the E3 ubiquitin ligase parkin activates signaling through the IκB kinase (IKK)/nuclear factor κB (NF-κB) pathway. Our analysis revealed that activation of this signaling cascade is causally linked to the neuroprotective potential of parkin. Inhibition of NF-κB activation by an IκB super-repressor or a kinase-inactive IKKβ interferes with the neuroprotective activity of parkin. Furthermore, pathogenic parkin mutants with an impaired neuroprotective capacity show a reduced ability to stimulate NF-κB-dependent transcription. Finally, we present evidence that parkin interacts with and promotes degradation-independent ubiquitylation of IKKγ/NEMO (NF-κB essential modifier) and TRAF2 [TNF (tumor necrosis factor) receptor-associated factor 2], two critical components of the NF-κB pathway. Thus, our results support a direct link between the neuroprotective activity of parkin and ubiquitin signaling in the IKK/NF-κB pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings do not preclude a role for the ubiquitination of parkin or parkin substrates via other linkages in distinct cellular pathways such as NF-jB signaling (K63, N-terminal/linear)”
From USP8 regulates mitophagy by removing K6‐linked ubiquitin conjugates from parkin (2014) · cites this paper as Henn et al, 2007
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis
Jiang, H., Ren, Y., Zhao, J., & Feng, J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh180 · Cited by 239 · cited 2×
“…cells against cell death induced by kainate, proteasomal inhibition, -synuclein, ceramide, manganese, dopamine, and unfolded protein stress (Imai et al., 2000; Petrucelli et al., 2002; Darios et al., 2003; Staropoli et al., 2003; Higashi et al., 2004; Jiang et al., 2004; Muqit et al., 2004).”
BackgroundA pervasive role of ubiquitin conjugation in activation and termination of IκB kinase pathways
Krappmann, D., & Scheidereit, C. (2005) · The EMBO Reports · doi:10.1038/sj.embor.7400380 · Cited by 128
Self-citation
Flagged first, then by citations
Research works printed but not linked: 47
- 10.1083/jcb.200502113 · DOI
- 10.1038/ncb0805-758 · DOI · Paper page
- 10.1093/hmg/ddg044 · DOI
- 10.1126/science.284.5412.309 · DOI
- 10.1016/S0092-8674(00)00126-4 · DOI · Paper page
- 10.1074/jbc.M413591200 · DOI
- 10.1042/BJ20031377 · DOI
- 10.1038/sj.emboj.7600808 · DOI
- 10.1101/gad.1228704 · DOI · Paper page
- 10.1186/1471-2202-5-14 · DOI
- 10.1111/j.1471-4159.2004.02854.x · DOI
- 10.1111/j.1471-4159.2004.02445.x · DOI
- 10.1074/jbc.C000447200 · DOI
- 10.1016/j.bbamcr.2005.05.009 · DOI
- 10.1038/ni0302-221 · DOI · Paper page
- 10.1038/33416 · DOI · Paper page
- Krappmann, 1996, Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo, EMBO J, 15, 6716, 10.1002/j.1460-2075.1996.tb01061.x · DOI
- 10.1074/jbc.M003902200 · DOI
- 10.1128/MCB.21.19.6640-6650.2001 · DOI
- 10.1038/nm1314 · DOI
- 10.1073/pnas.0405313101 · DOI
- 10.1093/hmg/ddh089 · DOI
- 10.1074/jbc.M510393200 · DOI · Paper page
- 10.1016/0896-6273(93)90315-I · DOI · Paper page
- 10.1046/j.1471-4159.2000.740443.x · DOI
- 10.1093/hmg/ddh012 · DOI
- 10.1016/j.neulet.2006.02.035 · DOI
- 10.1074/jbc.M306889200 · DOI
- 10.1016/S0896-6273(02)01125-X · DOI
- 10.1016/j.cbpa.2004.09.009 · DOI
- 10.1016/j.cub.2004.09.074 · DOI
- Rawal, 2003, New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism, Neurology, 60, 1378, 10.1212/01.WNL.0000056167.89221.BE · DOI
- 10.1074/jbc.M512649200 · DOI
- 10.1126/science.7544915 · DOI
- 10.1016/S0002-9440(10)61113-3 · DOI
- 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z · DOI
- 10.1093/hmg/ddi292 · DOI
- 10.1016/S0896-6273(03)00084-9 · DOI
- 10.1007/s00439-005-0038-4 · DOI
- 10.1128/MCB.23.6.2029-2041.2003 · DOI
- 10.1093/hmg/ddi413 · DOI
- 10.1007/s00439-003-1074-6 · DOI
- Winklhofer KF Tatzelt J (2006) in Molecular chaperones in health and diseases, The role of chaperones in Parkinson's disease and prion diseases, ed Gaestel M (Springer, Berlin), pp 221–258. · DOI
- 10.1074/jbc.M104873200 · DOI
- 10.1074/jbc.M306769200 · DOI
- 10.1074/jbc.M407724200 · DOI
- 10.1016/S0896-6273(03)00143-0 · DOI
Cited by
Sorted by citations
Mitochondrial dysfunction in Parkinson's disease
Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688
Self-citationUSP8 regulates mitophagy by removing K6‐linked ubiquitin conjugates from parkin
Durcan, T. M., Tang, M. Y., Pérusse, J. R., Dashti, E. A., Aguileta, M. A., McLelland, G., Gros, P., Shaler, T. A., Faubert, D., Coulombe, B., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201489729 · Cited by 375
Cellular Specificity of NF-κB Function in the Nervous System
Dresselhaus, E. C., & Meffert, M. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01043 · Cited by 345
Ubiquitination in postsynaptic function and plasticity
Mabb, A. M., & Ehlers, M. D. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-104129 · Cited by 255
Inflammation is genetically implicated in Parkinson’s disease
Dzamko, N., Geczy, C. L., & Halliday, G. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.028 · Cited by 222
Metadata
- Authors
- Henn, I. H., Bouman, L., Schlehe, J. S., Schlierf, A., Schramm, J. E., Wegener, E., Nakaso, K., Culmsee, C., Berninger, B., Krappmann, D., Tatzelt, J., & Winklhofer, K. F.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-02-21
- Volume
- 27
- Issue
- 8
- Pages
- 1868-1878
- ISSN
- 0270-6474
- 1529-2401
- Cited by
- 173
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review